ATH 0.00% 0.4¢ alterity therapeutics limited

Reading further into this new marker myoinsitol. In the studies...

  1. 980 Posts.
    lightbulb Created with Sketch. 101
    Reading further into this new marker myoinsitol. In the studies within the link I provided. They found a rise in this chemical, affected neurodegenerate disease such as alzhiemers and huntingtons disease, in which, AUSTEDO treats Huntingtons disease. I personally find this an awesome and interesting link, and an obvious area Dr Stamler is very privy too given his alterations and apporal of AUSTEDO.

    If he can get AUSTEDO to market, he sure can get ATH434 to market, so glad I found this gem of a stock.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $18.62M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $306 101.6K

Buyers (Bids)

No. Vol. Price($)
43 57921134 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 128926244 20
View Market Depth
Last trade - 12.22pm 05/09/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.